Scinai Immunotherapeutics Ltd. (SCNI)
NASDAQ: SCNI · Real-Time Price · USD
3.400
+0.040 (1.19%)
Dec 20, 2024, 4:00 PM EST - Market closed
Scinai Immunotherapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 3 | 3 | 10 | 43 | 32 | 93 | |
| Market Cap Growth | -17.93% | -74.89% | -76.24% | 34.05% | -65.34% | 199.76% | |
| Enterprise Value | 3 | 16 | 19 | 55 | 59 | 105 | |
| Last Close Price | 3.40 | 5.95 | 29.60 | 235.00 | 281.00 | 929.00 | |
| PB Ratio | 0.29 | -0.57 | -5.86 | 44.21 | -2.22 | -1.44 | |
| P/TBV Ratio | 0.29 | - | - | 44.21 | - | - | |
| EV/EBITDA Ratio | - | - | - | - | 6.62 | - | |
| EV/EBIT Ratio | - | - | - | - | 7.98 | - | |
| Debt / Equity Ratio | 0.12 | -4.50 | -12.24 | 29.52 | -4.60 | -2.02 | |
| Debt / EBITDA Ratio | - | - | - | - | 6.87 | - | |
| Quick Ratio | 0.83 | 2.94 | 6.07 | 7.15 | 0.15 | 3.84 | |
| Current Ratio | 1.16 | 3.06 | 6.15 | 7.30 | 0.17 | 3.86 | |
| Return on Equity (ROE) | 128.46% | - | - | - | - | - | |
| Return on Assets (ROA) | -33.22% | -27.24% | -23.39% | -26.97% | 5.31% | -44.20% | |
| Return on Capital (ROIC) | -36.15% | -33.91% | -27.79% | -28.97% | 7.72% | -75.70% | |
| Earnings Yield | 161.92% | -250.86% | -56.18% | -18.90% | -13.75% | -116.85% | |
| FCF Yield | -232.05% | -386.67% | -78.52% | -17.42% | -242.88% | -90.41% | |
| Buyback Yield / Dilution | -57.22% | -107.22% | -33.57% | -27.37% | -35.70% | -24.95% | |
| Total Shareholder Return | -57.22% | -107.22% | -33.57% | -27.37% | -35.70% | -24.95% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.